ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.316-7C>G (rs34483965)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000445651 SCV000791082 likely pathogenic beta Thalassemia 2017-04-25 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781440 SCV000919460 uncertain significance not specified 2018-05-30 criteria provided, single submitter clinical testing Variant summary: HBB c.316-7C>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 3/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4.1e-06 in 246028 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.316-7C>G has been reported in the literature in unaffected heterozygous carriers and an individual affected with mild Beta Thalassemia intermedia. These data do not allow any conclusion about variant significance. One publication tested the effect of mutation in the pyrimidine tract of intron 2 of HBB and showed that changes in this region affected 3' end processing; however, the variant was tested in conjunction with other variants, so the specific effect of the variant is unknown (Millevoi_2002). Both ithanet and GeneReviews classified the variant as pathogenic/causal while multiple papers noted variant as a silent BTHAL mtuation. HbVar noted variant with various phenotypes (silent or mild thalasemia) when associated with different alleles. Based on the evidence outlined above, the variant was classified as uncertain significance until additional clinical data is reported.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001284152 SCV001469778 uncertain significance not provided 2019-11-12 criteria provided, single submitter clinical testing
GeneReviews RCV000445651 SCV000537298 pathogenic beta Thalassemia 2015-05-14 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.